Literature DB >> 17491692

Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus.

Charles Sia1.   

Abstract

Functional polarization of T helper (Th) subsets of lymphocytes has been implicated in promoting or conferring risk to Type 1 diabetes mellitus (T1DM) development in human and diabetic animal models. It is assumed that an immoderate preponderance of type 1 immunity establishes the prerequisite for this development. Over the past years, various immune-intervention strategies have been tested to protect diabetic animals from developing overt diabetes. These protocols implicate a protective mechanism that is attributed to a change in the set of autoreactive Th cells from their Th1 to the Th2 phenotype. The studies were aimed at improving the effectiveness of Th2 cells to secrete the principal cytokines, IL-4 and IL-10, in order to mediate protection from diabetes in NOD mice. In contrast, some immune-modulation protocols utilizing non-specific reagents report that diabetes protection is apparently attributed to preferential survival of both Th1 and Th2 cells, rather than via a shift from their Th1 to Th2 phenotypes. Even though we know that excessive immune responses against self antigens are also controlled and terminated by regulatory T cells, this article focuses on the polarization of Th effector cells and discusses the controversial findings regarding the Th1/Th2 hypothesis to draw a conclusion on its relevance in T1DM from the existing knowledge.

Entities:  

Year:  2006        PMID: 17491692      PMCID: PMC1783566          DOI: 10.1900/RDS.2005.2.182

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  43 in total

Review 1.  Antigen-specific therapy for autoimmune disease.

Authors:  L C Harrison; D A Hafler
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

2.  Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus.

Authors:  M A Berman; C I Sandborg; Z Wang; K L Imfeld; F Zaldivar; V Dadufalza; B A Buckingham
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

3.  Sequential conversion of the redox status of macrophages dictates the pathological progression of autoimmune diabetes.

Authors:  Yukie Murata; Michiko Amao; Junji Hamuro
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

4.  Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia.

Authors:  D Ross Laybutt; Hideaki Kaneto; Wendy Hasenkamp; Shane Grey; Jean-Christophe Jonas; Dennis C Sgroi; Adam Groff; Christiane Ferran; Susan Bonner-Weir; Arun Sharma; Gordon C Weir
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

5.  Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice.

Authors:  H Noorchashm; D J Moore; L E Noto; N Noorchashm; A J Reed; A L Reed; H K Song; R Mozaffari; A M Jevnikar; C F Barker; A Naji
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

Review 6.  Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?

Authors:  A Rabinovitch
Journal:  Diabetes       Date:  1994-05       Impact factor: 9.461

7.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.

Authors:  B J Miller; M C Appel; J J O'Neil; L S Wicker
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

Review 8.  Lymphokine production by human T cells in disease states.

Authors:  S Romagnani
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Distinct functional phenotypes of cloned Ia-restricted helper T cells.

Authors:  J Kim; A Woods; E Becker-Dunn; K Bottomly
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Novel biomarkers in type 1 diabetes.

Authors:  Yulan Jin; Jin-Xiong She
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.

Authors:  Paolo Fiorina; Mollie Jurewicz; Andrea Augello; Andrea Vergani; Shirine Dada; Stefano La Rosa; Martin Selig; Jonathan Godwin; Kenneth Law; Claudia Placidi; R Neal Smith; Carlo Capella; Scott Rodig; Chaker N Adra; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

Review 3.  Review of the literature: integrating psychoneuroimmunology into pediatric chronic illness interventions.

Authors:  Jack H Nassau; Karen Tien; Gregory K Fritz
Journal:  J Pediatr Psychol       Date:  2007-09-10

4.  Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice.

Authors:  Cheng Li; Lijuan Zhang; Yanyan Chen; Xiaojie Lin; Tang Li
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

5.  A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice.

Authors:  Ming S Lin; Hubert M Tse; Meghan M Delmastro; Suzanne Bertera; Caterina T Wong; Robert Lakomy; Jing He; Martha M Sklavos; Gina M Coudriet; Massimo Pietropaolo; Massimo M Trucco; Jon D Piganelli
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 6.  miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.

Authors:  Ying Zheng; Zhen Wang; Zhiguang Zhou
Journal:  Cell Mol Immunol       Date:  2017-03-20       Impact factor: 11.530

7.  Active Subjects With Autoimmune Type 1 Diabetes Have Better Metabolic Profiles Than Sedentary Controls.

Authors:  M Adamo; R Codella; F Casiraghi; A Ferrulli; C Macrì; E Bazzigaluppi; I Terruzzi; L Inverardi; C Ricordi; L Luzi
Journal:  Cell Transplant       Date:  2016-09-20       Impact factor: 4.064

Review 8.  Immunopathology of the human pancreas in type-I diabetes.

Authors:  Sarah J Richardson; Abby Willcox; Adrian J Bone; Noel G Morgan; Alan K Foulis
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

9.  The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.

Authors:  Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabo
Journal:  J Endocrinol       Date:  2008-06-18       Impact factor: 4.286

10.  Analysis of islet inflammation in human type 1 diabetes.

Authors:  A Willcox; S J Richardson; A J Bone; A K Foulis; N G Morgan
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.